Telomir Pharmaceuticals (NASDAQ:TELO) Trading Down 1.8%

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) fell 1.8% during trading on Wednesday . The company traded as low as $5.56 and last traded at $5.60. 10,501 shares traded hands during trading, a decline of 81% from the average session volume of 55,439 shares. The stock had previously closed at $5.70.

Telomir Pharmaceuticals Trading Down 1.8 %

The company has a 50 day moving average of $6.56.

Telomir Pharmaceuticals (NASDAQ:TELO) last released its earnings results on Monday, May 13th. The company reported ($0.23) EPS for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Telomir Pharmaceuticals stock. Suncoast Equity Management purchased a new position in shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 24,391 shares of the company’s stock, valued at approximately $126,000. Suncoast Equity Management owned about 0.08% of Telomir Pharmaceuticals at the end of the most recent reporting period.

About Telomir Pharmaceuticals

Telomir Pharmaceuticals, Inc, a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy health problems.